Will Earnings Lift Us Back Up?<br />By Rev Shark<br />RealMoney.com Contributor<br />7/13/2009 8:12 AM EDT <br /><br />"What we see depends mainly on what we look for." <br /><br />--John Lubbock <br />After a couple weeks of slow and dreary trading, the action should pick up this week as major earnings reports start to hit. Financial stocks Goldman Sachs (GS) , JPMorgan Chase (JPM) , Bank of America (BAC) , Citigroup (C) and General Electric (GE) will be the primary focus this week, but we also have technology names Novellus (NVLS) , Intel (INTC) , Google (GOOG) and International Business Machines (IBM) that will help to set the tone. <br /><br />As always, the key to earnings is expectations. Lousy reports when expectations are low will often generate positive responses and good reports when expectations are high will tend to generate negative responses. <br /><br />In the first quarter of this year, expectations were pretty low, and reports came in fairly well, which gave the market a boost that kept us running through June. Earnings helped to produce the psychology that kept the bounce going from the March low. Things just didn't seem that bad despite all the economic news out there, which wasn't nearly as pleasant. <br /><br />Since mid-June the market has started to roll over, and the psychology has become more negative. The big question is whether earnings can shift the tide and help repair the technical damage that has been done. <br /><br />Analysts have been saying that expectations are too low. This morning Meredith Whitney is upgrading Goldman Sachs in front of its report this week, and Jeffries and Merriman are saying that consensus estimates appear too low for Google. <br /><br />The problem is that when analysts raise the very expectations that they claim are too low, they undermine their argument and set up the dynamic for a sell-on-the-news reaction. The key will be how much stocks run up in front of the reports. <br /><br />Earnings are a very tricky game to play, but a lot of folks like to bet on them. Many investors like to think they have some special insight into how a stock will react to earnings, but it is almost always just a gamble. Not only do you have to guess how earnings will be reported and the tone of the report but you have to gauge expectations and the psychology of the market. There are thousands of investors trying to game each important earnings report, and none of them have any edge unless they have some special inside information. <br /><br />There always is plenty of volatile action after a report is out, so there is no need to bet on a report unless you enjoy the adrenaline rush of gambling. A lot of gambling takes place during earnings season, which makes for more interesting action and creates good opportunities for those who like to play the reactions as the news hits. <br /><br />I'm a bit concerned that, while expectations may not be too high, the overall mood is rather sanguine. We will have a good test this week from the likes of Goldman Sachs, which everyone expects to issue a blow out report. <br /><br />Technical conditions suggest that earnings will not shift the trend back up, but, at a minimum, we certainly can expect a hiccup or two that will catch both bulls and bears by surprise. <br /><br />This morning the early action is flat. Asian markets were under pressure while Europe is around flat. Oil and gold are flat, and the big news so far is the upgrade of Goldman Sachs by Meredith Whitney. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: PHG +4.3%... Select financial names showing strength boosted by Meredith Whitney GS upgrade and comments about the sector: HBAN +7.0%, AIG +6.8%, BAC +5.2% (Meredith Whitney appears on CNBC; says BAC is cheapest of banks relative to tangible book; also BofA balking at paying fees for guarantees: Report - Reuters), DFS +5.1%, FITB +3.7%, GS +3.5% (raised to buy from Neutral by Meredith Whitney - DJ), C +3.5%, MS +3.1%, JPM +2.4% ... Other news: SNSS +35.3% (light volume; receives $1.5 mln milestone payment from Biogen), HOV +14.1% (still checking), RINO +8.9% (approved for Nasdaq Listing), OSIP +7.9% (New data from Ph. 3 SATURN study showed Tarceva improved overall survival when used immediately after initial chemotherapy in patients with NSCLC; upgraded to Outperform at RBC Capital Mkts), STP +5.8% (signs strategic agreement to develop an aggregate 1.8GW of projects in China; ALSO Hoku Scientific and Suntech amend supply agreement to adjust milestone and shipping schedule), OCLS +5.5% (entered into an agreement with OroScience), BSX +4.4% (announces European approval for Its LATITUDE Patient Management System ), ARST +3.9% (Cramer makes positive comments on MadMoney), ELN +2.1% (announce phase 1 data showing ELND005 achieves desired concentrations in brain tissue and cerebrospinal fluid), SCHW +1.2% (mentioned positively in Barron's)... Analyst comments: JASO +4.5% (initiated with a Buy at Needham), KFT +1.6% (upgraded to Outperform at BMO Capital Markets; tgt raised to $31), SNDK +1.5% (upgraded to Overweight at Thomas Weisel).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: ADY -19.1%, EXPD -11.6% (light volume), FAST -7.8%, CELL -5.8% (also announces an offering of 15 mln common shares by selling shareholder) ... Select oil/gas names ticking lower: STO -1.3%, PTR -1.3%... Other news: BEAT -37.1% (announces Highmark Medicare Services reimbursement reduction regarding CPT Code 93229; co withdraws previously stated FY09 guidance; ests and tgt lowered to $5 at Jefferies and downgraded to Mkt Perform at Leerink Swann), HOKU -12.3% (provides update to polysilicon production strategy; also Hoku Scientific and Suntech amend supply agreement to adjust milestone and shipping schedules), TSM -3.9% (still checking), CINF -2.0% (announces Q2 catastrophe losses), ISLE -1.2% (light volume; filed for a $300 mln mixed shelf offering)... Analyst comments: IPI -3.2% (downgraded to Underperform at Oppenheimer; firm cuts their '09E EPS by 50%).